CLINICAL TRIALS PROFILE FOR ASIMADOLINE

Clinical Trials for Asimadoline

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00244153 ↗	Intraarticular Opioids Vs Glucocorticosteroids in Gonarthritis	Unknown status	Charite University, Berlin, Germany	Phase 1/Phase 2	Intraarticular application of opioids versus glucocorticosteroids versus placebo in knee arthritis study goals: assessment of effectiveness and tolerability of locally applied morphine, dexamethasone or placebo in knee arthritis
NCT00443040 ↗	Asimadoline for the Treatment of Post-Operative Ileus	Terminated	RTI Health Solutions	Phase 2	The purpose of this study is to evaluate the safety and efficacy of asimadoline in patients who have undergone a laparoscopic segmental colectomy and determine whether it reduces the time to recovery of bowel function compared to placebo.
NCT00443040 ↗	Asimadoline for the Treatment of Post-Operative Ileus	Terminated	Tioga Pharmaceuticals	Phase 2	The purpose of this study is to evaluate the safety and efficacy of asimadoline in patients who have undergone a laparoscopic segmental colectomy and determine whether it reduces the time to recovery of bowel function compared to placebo.
NCT00454688 ↗	Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome	Completed	RTI Health Solutions	Phase 2	The purpose of this study is to evaluate the safety and efficacy of different doses of asimadoline in the treatment of patients with irritable bowel syndrome.
NCT00454688 ↗	Asimadoline for the Treatment of Subjects With Irritable Bowel Syndrome	Completed	Tioga Pharmaceuticals	Phase 2	The purpose of this study is to evaluate the safety and efficacy of different doses of asimadoline in the treatment of patients with irritable bowel syndrome.

Clinical Trial Conditions for Asimadoline

Condition Name

Condition Name for
Intervention	Trials
Irritable Bowel Syndrome	2
Pruritus	1
Rheumatic Disease	1
Atopic Dermatitis	1

Condition MeSH

Condition MeSH for
Intervention	Trials
Syndrome	3
Irritable Bowel Syndrome	3
Pruritus	1
Ileus	1

Clinical Trial Locations for Asimadoline

Trials by Country

Trials by Country for
Location	Trials
United States	91
Germany	1

Trials by US State

Trials by US State for
Location	Trials
Missouri	4
Ohio	3
Minnesota	3
New York	3
North Carolina	3

Clinical Trial Progress for Asimadoline

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase	Trials
Phase 3	1
Phase 2	4
Phase 1/Phase 2	1

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase	Trials
Completed	5
Unknown status	1
Terminated	1

Clinical Trial Sponsors for Asimadoline

Sponsor Name

Sponsor Name for
Sponsor	Trials
Tioga Pharmaceuticals	5
RTI Health Solutions	3
Mayo Clinic	1

Sponsor Type

Sponsor Type for
Sponsor	Trials
Other	5
Industry	5